ESSA Pharma snags $49m in funding, Pfizer among the investors

Vancouver, British Columbia-based ESSA Pharma secured US$49 million in a public offering that included investments by the pharmaceutical company's venture capital backers.

DealsCanadaNorth AmericaUSHealthcareBriefs